Praluent (alirocumab)

pCPA File Number: 22873
Negotiation Status:
Concluded without agreement
Indication(s):
Primary hypercholesterolemia (non-familial and heterozygous familial) and Acute coronary syndrome
Sponsor/Manufacturer:
Sanofi-Aventis Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: